comparemela.com

Latest Breaking News On - Mark bieniarz - Page 1 : comparemela.com

First Patient Enrolled in Abiomed s RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock

First trial in AMI cardiogenic shock to use the FDA’s EFIC protocol

United statesChuck simontonJohnson medtechColl cardiolMark bieniarzAbiomed incMexico heart instituteJapanese circulation societyDrug administrationNational cardiogenic shock initiativeUnited states foodInova studyNew mexico heart instituteNew mexico heartKansas city cardiomyopathy questionnaire

Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock

Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).

United statesJohnson medtechChuck simontonMark bieniarzDrug administrationMexico heart instituteNational cardiogenic shock initiativeUnited states foodInova studyNew mexico heart instituteNew mexico heartKansas city cardiomyopathy questionnaireCardiogenic shockHealth careMyocardial infarction

FDA approves heart pump study in New Mexico

An FDA-approved heart pump study is being conducted here in New Mexico with the goal of improving recovery for heart attack patients.

New mexicoUnited statesMark bieniarzMexico heart institute at lovelace medical centerNew mexico heart instituteLovelace medical center

vimarsana © 2020. All Rights Reserved.